Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by IQVIA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IQVIA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Debunking value, access, & pricing myths: Episode 2 | Pricing in Germany is always transparent

14:58
 
Share
 

Manage episode 514005879 series 2286431
Content provided by IQVIA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IQVIA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Welcome to “Debunking Value, Access & Pricing Myths”—a podcast series from IQVIA’s Value and Payer Evidence team where we explore the transformations underway in healthcare pricing and market access - challenging outdated norms and shedding light on the new realities shaping our work.
In the second episode, your host Rebecca Coady, Principal at IQVIA, is joined by her colleague Katrin Lamp. Together, they take on a myth “Pricing in Germany is always transparent.”
Katrin, who is a principal at IQVIA and an expert in the German market, shares her perspectives on the major changes to drug pricing in the largest EU pharmaceutical market, Germany, and what this means for pricing strategy development and price management – they cover what you need to know about the changing pricing rules, including the opportunity for confidential pricing.

  continue reading

68 episodes

Artwork
iconShare
 
Manage episode 514005879 series 2286431
Content provided by IQVIA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IQVIA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Welcome to “Debunking Value, Access & Pricing Myths”—a podcast series from IQVIA’s Value and Payer Evidence team where we explore the transformations underway in healthcare pricing and market access - challenging outdated norms and shedding light on the new realities shaping our work.
In the second episode, your host Rebecca Coady, Principal at IQVIA, is joined by her colleague Katrin Lamp. Together, they take on a myth “Pricing in Germany is always transparent.”
Katrin, who is a principal at IQVIA and an expert in the German market, shares her perspectives on the major changes to drug pricing in the largest EU pharmaceutical market, Germany, and what this means for pricing strategy development and price management – they cover what you need to know about the changing pricing rules, including the opportunity for confidential pricing.

  continue reading

68 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play